Salivary and Urinary Total Antioxidant Capacity as Biomarkers of Oxidative Stress in Humans

Table 1

Infection and oral and renal status.

References	Case-control studies	Salivary TAC; percentage ()	Urinary TAC; percentage ()	Treatment effect; percentage ()
[98, 112, 130, 148, 149]	Infection	100% (3/3)	(100%, 2/2)	Salivary TAC; HAART in HIV+
[16, 45, 47, 60, 61, 64, 72, 73, 75, 78, 84, 90, 99, 103, 104, 122, 124, 125]	Caries	↑ 81.2% (13/16); ↔ 6.3% (1/16); ↓ 12.5% (2/16)		Dental hygiene procedures; ↑ 100% (3/3)
[26, 28, 34, 35, 37, 39, 40, 44, 52, 53, 66, 68, 76, 87, 89, 95, 96, 100, 101, 110, 114, 115]	Periodontitis	66.7% (14/21); 23.8% (5/21); 9.5% (2/21)		Dental hygiene procedures or scaling and root planing; 50% (3/6); 50% (3/6)
[13–15, 17, 22–24, 29, 36, 49, 83, 88, 92, 113, 128]	Severe oral diseases	66.7% (10/15); 26.7% (4/15); 6.6% (1/15)
[30, 31, 86, 142, 154, 158, 162, 179]	Renal diseases	50% (2/4); 50% (2/4)	60% (3/5); 20% (1/5); 20% (1/5)

HAART: highly active antiretroviral therapy; TAC: total antioxidant capacity; : increase; : decrease; : unchanged.